Polidocanol Foam With or Without Transdermal Laser in Varicose Veins
Recruiting
N/A
Interventional Study
Varicose Veins
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 102 (estimated)
- Sponsor
- Hospital Universitario Pedro Ernesto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomized, parallel clinical trial with blinded outcome assessment will compare the clinical and aesthetic outcomes of polidocanol foam sclerotherapy alone versus polidocanol foam associated with long-pulse 1064 nm Nd:YAG transdermal laser in the treatment of lower-limb tributary varicose veins. The primary endpoint is venous occlusion rate at 30 days, assessed by Doppler ultrasound. Seconda…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 21 to 75 years
* CEAP clinical class 1-3
* Lower limb tributary varicose veins 2,5 to 4,0 mm in diameter on Doppler ultrasound.
* Vein depth up to 4 mm from the skin surface.
* Tributary vein may originate from the great or small saphenous vein as long as the saphenous vei…
Contacts